Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30

Clinical trial NCT06778304 · COMPLETED

Trial details

NCT number: NCT06778304
Sponsor: West China Second University Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence Healthy Volunteers Pharmacokinetics Safety Immunogenicity

Start date: 2021-01-04
Primary completion: 2021-11-16
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.